PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 1, 2004 Subscribe to this News Feed    
 

BioPlus® Specialty Pharmacy announces decision to use Warrick Pharmaceuticals generic Ribavirin.

BioPlus® Specialty Pharmacy announces decision to use Warrick Pharmaceuticals generic Ribavirin.

ALTAMONTE SPRINGS, FL (PRWEB) May 1, 2004 --As a disease management specialty pharmacy dedicated to pharmaceutical care, we felt it was our responsibility to analyze the new generic Ribavirin market. Therefore, in addition to using branded Ribavirin, we have decided to include Warrick Pharmaceuticals generic form of Ribavirin for treating Hepatitis C patients. This cost effective form of Ribavirin is manufactured at the same facility as Scherings branded Rebetol®. As the pioneers in Hepatitis specialty care, BioPlus is pleased to provide a generic option along with our personalized disease management services," said Stephen C. Vogt, PharmD and CEO of BioPlus Specialty Pharmacy Services, Inc.

BioPlus Specialty Pharmacy Services also provides disease management for other chronic illnesses that include:

•   Multiple Sclerosis
•   Hepatitis
•   Arthritis
•   Cancer
•   HIV / AIDS
•   Psoriasis
•   Crohns disease

BioPlus disease management services include:

•   Detailed insurance investigation for patients, determining best area of coverage
•   Formulary management
•   Ongoing patient counseling, educating and side effects management
•   Available pharmacists 24 hours a day 7 days a week.
•   Refill tracking and monitoring to ensure continual compliance
•   Free medication delivery
•   Utilization data

Contact BioPlus at 888-292-0744 or www.bioplus.net

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Enoch Strollo
BIOPLUS SPECIALTY PHARMACY
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.